IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer
2022 · Proceedings of the National Academy of Sciences · 565 citations
https://doi.org/10.1073/pnas.2201376119
Q
Qingfeng Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
177
Papers
4.9K
Citations
34
h-index
59
i10-index
Qingfeng Chen is an academic researcher from Qingdao University. The author has contributed to research in topics: Immune Cell Function and Interaction & CAR-T cell therapy research & Immunotherapy and Immune Responses. The author has an h-index of 34, co-authored 151 publications.
ORCID: 0000-0001-6437-1271Papers by this author
worksSingle-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
2021 · Cancer Discovery · 487 citations
https://doi.org/10.1158/2159-8290.cd-21-0683
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
2022 · Nature Communications · 152 citations
https://doi.org/10.1038/s41467-022-31764-9
Opposing activities of the <scp>R</scp> as and <scp>H</scp> ippo pathways converge on regulation of <scp>YAP</scp> protein turnover
2014 · The EMBO Journal · 125 citations
https://doi.org/10.15252/embj.201489385
Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapy
2019 · JHEP Reports · 60 citations
https://doi.org/10.1016/j.jhepr.2019.11.006
Nitric Oxide-Producing Multiple Functional Nanoparticle Remodeling Tumor Microenvironment for Synergistic Photodynamic Immunotherapy against Hypoxic Tumor
2025 · ACS Nano · 38 citations
https://doi.org/10.1021/acsnano.4c16329
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat